US, Greater China Healthcare-Focused Vivo Capital Garners $1.28B For Ninth PE Fund

Login to View

Vivo Capital, a California-based investment firm which backs healthcare companies in the U.S. and Greater China, has rounded up over US$1.28 billion for its ninth private equity fund, Vivo Capital Fund IX LP, according to the company’s latest regulatory filing with the SEC.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in